Clinical Trial Update: Nonmyeloablative Stem Cell Transplant in Children with Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor [Phase 2]

View source ↗

Summary

A Phase 2 nonmyeloablative stem cell transplant trial in children with sickle cell disease using a major ABO-incompatible matched sibling donor is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: University of Calgary | Conditions: Sickle Cell Disease, Stem Cell Transplant Complications | Phase 2 | Status: RECRUITING